Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Kennedy Walks a Tightrope on Trump Deal for Obesity Drugs

The weight loss medicines are proving to be a test case for Robert F. Kennedy Jr., the health secretary, in straddling divisions between his supporters and the president.

Dani Blum
Author: Dani Blum

Written by

Dani Blum and Rebecca Robbins

in

Diabetes, Diet and Nutrition, Drugs (Pharmaceuticals), Eli Lilly and Company, Food and Drug Administration, GLP-1 RAs (Drug), Health and Human Services Department, Health Insurance and Managed Care, Kennedy, Robert F Jr, Medicare, Novo Nordisk A/S, Ozempic (Drug), Prices (Fares, Fees and Rates), Regulation and Deregulation of Industry, Trump, Donald J, United States Politics and Government
←In Death, Poet Andrea Gibson Gets a Film That Celebrates Life
Today’s Top Directors Have Some Issues With Gen Z→

More posts

  • Wes Streeting calls Putin a ‘cold-blooded killer’ as he meets Zelensky in Kyiv

  • Just 22 Times Alexander Skarsgård Served Really, Really Interesting Looks The World Didn’t See Coming

  • Just 22 Times Alexander Skarsgård Served Really, Really Interesting Looks The World Didn’t See Coming

  • Rugby union: England run up record win over New Zealand

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube